UK markets closed

RedHill Biopharma Ltd. (RDHL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4218-0.0071 (-1.66%)
As of 01:42PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,530
6,530
61,800
85,757
64,359
Cost of revenue
3,459
3,459
33,337
49,406
36,892
Gross profit
3,071
3,071
28,463
36,351
27,467
Operating expenses
Research development
3,528
3,528
7,279
29,498
16,491
Selling general and administrative
30,975
30,975
64,028
87,988
74,660
Total operating expenses
-9,561
-9,561
71,307
117,486
91,151
Operating income or loss
12,632
12,632
-42,844
-81,135
-63,684
Interest expense
367
367
41,333
16,567
12,450
Total other income/expenses net
13,442
13,442
13,382
-28
85
Income before tax
23,916
23,916
-71,669
-97,744
-76,173
Income from continuing operations
23,916
23,916
-71,669
-97,744
-76,173
Net income
23,916
23,916
-71,669
-97,744
-76,173
Net income available to common shareholders
23,916
23,916
-71,669
-97,744
-76,173
Basic EPS
-8.00
-
-48.00
-84.00
-79.35
Diluted EPS
-8.00
-
-48.00
-84.00
-79.35
Basic average shares
2,462
-
1,541
1,163
959.954
Diluted average shares
2,462
-
1,541
1,163
959.954